Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07771140
Recruiting
A Phase I Clinical Trial to Evaluate HECN30227 Injection in Healthy Subjects and Subjects With Chronic Hepatitis B
Phase 1 · China · 1 site
Registry update: 18 Aug 2026
NCT06324240
Recruiting
Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer
Phase 1 · United States · 4 sites
Registry update: 26 Jan 2026
NCT07258849
Recruiting
A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis
Phase 1 · Germany, United States · 10 sites
Registry update: 23 Jun 2026
NCT07116486
Recruiting
A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma
Phase 1 · United States · 1 site
Registry update: 10 Jun 2026
NCT07359625
Recruiting
Effects of Ketone Bodies on Insulin Sensitivity
Not applicable · Denmark · 1 site
Registry update: 22 Jan 2026
NCT07224971
Recruiting
Impact of Circadian Rhythm on Immunotherapy
Phase 2 · United States · 1 site
Registry update: 9 Dec 2025
NCT07293429
Recruiting
Combined Posture Correction and Resistive Respiratory Muscles Training in COPD With FHP
Not applicable · Pakistan · 1 site
Registry update: 5 Jan 2026
NCT07417280
Recruiting
LIFUS For Neurological Disorders
Not applicable · Canada · 1 site
Registry update: 13 Aug 2026
NCT07578220
Recruiting
A Randomized Trial of Ultrasound-Guided Acupotomy for Ankylosing Spondylitis
Not applicable · China · 1 site
Registry update: 15 Oct 2026
NCT06807281
Recruiting
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
Phase 3 · China, Germany, Spain, Hungary, Japan, Mexico, Poland, United States · 43 sites
Registry update: 5 Nov 2026
NCT06659705
Recruiting
Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI)
Phase 2 · France · 1 site
Registry update: 15 Apr 2026
NCT07793396
Recruiting
Prospective Study of Eslicarbazepine in Adults With Focal-Onset Seizures
Not applicable · Pakistan · 1 site
Registry update: 9 Sept 2026
NCT07292168
Recruiting
A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1
Phase 1/2 · Russia · 5 sites
Registry update: 21 Jan 2026
2025-520676-26-00
Recruiting
Phase II trial of amivantamab plus monochemotherapy in platinum unfit NSCLC patients with EGFR exon20 insertion mutations
Phase 2 · Italy · 14 sites
Registry update: 24 Jul 2026
NCT07042802
Recruiting
A Study of LBL-024 in Combination With Paclitaxel ± Bevacizumab for the Treatment of Platinum-resistant Ovarian Cancer
Phase 1/2 · China · 13 sites
Registry update: 13 Aug 2026
NCT07116031
Recruiting
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
Phase 2 · Belgium, Canada, China, Germany, Spain, France, United Kingdom, Israel, Italy, Japan, Netherlands, United States · 35 sites
Registry update: 22 Sept 2026
NCT07093554
Recruiting
Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple Myeloma
Phase 1 · United States · 1 site
Registry update: 5 Jan 2026
NCT07174687
Recruiting
SGLT2 Inhibitors in Geographic Atrophy
Phase 2 · United States · 1 site
Registry update: 26 Aug 2026
NCT07126509
Recruiting
Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma
Not applicable · United States · 1 site
Registry update: 17 Feb 2026
NCT06524544
Recruiting
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Phase 3 · United States · 163 sites
Registry update: 4 Nov 2026

Ordered by registry start date. Freshness and sponsorship never change the order.